ZEPP HEALTH CORP Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
ZEPP HEALTH CORP (ZEPP) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-04-24
CNY
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|
| 2023-12-31 | 0.00 CNY 20-F · filed 2024-04-23 |
| 2022-12-31 | 13.86M CNY 20-F · filed 2024-04-23 |
| 2021-12-31 | 0.00 CNY 20-F · filed 2024-04-23 |
| 2020-12-31 | 0.00 CNY 20-F · filed 2022-04-28 |
| 2019-12-31 | 2.38M CNY 20-F · filed 2022-04-28 |
| 2018-12-31 | 0.00 CNY 20-F · filed 2021-04-19 |
| 2017-12-31 | 0.00 CNY 20-F · filed 2020-04-23 |
| 2016-12-31 | 0.00 CNY 20-F · filed 2019-04-12 |
USD
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-04-24 |
| 2024-12-31 | $7.26M 20-F · filed 2026-04-24 |
| 2023-12-31 | $0.00 20-F · filed 2026-04-24 |
| 2022-12-31 | $2.00M 20-F · filed 2025-04-25 |